Singapore markets closed
Straits Times Index
3,332.80 -10.55 (-0.32%) Nikkei
39,583.08 +241.54 (+0.61%) Hang Seng
17,718.61 +2.14 (+0.01%) FTSE 100
8,164.12 -15.56 (-0.19%) Bitcoin USD
60,818.60 +128.45 (+0.21%) CMC Crypto 200
1,262.72 -21.11 (-1.64%)
Rani Therapeutics Holdings, Inc. (RANI)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 99.95M |
| Enterprise value | 95.78M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 13.51 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -1.42 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.26 |
| 52-week change 3 | -5.94% |
| S&P500 52-week change 3 | 22.55% |
| 52-week high 3 | 8.7500 |
| 52-week low 3 | 1.8200 |
| 50-day moving average 3 | 5.3434 |
| 200-day moving average 3 | 3.5903 |
Share statistics
| Avg vol (3-month) 3 | 145.76k |
| Avg vol (10-day) 3 | 64.61k |
| Shares outstanding 5 | 26.3M |
| Implied shares outstanding 6 | 51.68M |
| Float 8 | 12.71M |
| % held by insiders 1 | 48.88% |
| % held by institutions 1 | 13.97% |
| Shares short (14 Jun 2024) 4 | 745.44k |
| Short ratio (14 Jun 2024) 4 | 9.35 |
| Short % of float (14 Jun 2024) 4 | 5.67% |
| Short % of shares outstanding (14 Jun 2024) 4 | 2.83% |
| Shares short (prior month 15 May 2024) 4 | 871.21k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -53.03% |
| Return on equity (ttm) | -172.96% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -62.73M |
| Net income avi to common (ttm) | -33.08M |
| Diluted EPS (ttm) | -1.2900 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 39.58M |
| Total cash per share (mrq) | 1.5 |
| Total debt (mrq) | 35.41M |
| Total debt/equity (mrq) | 243.62% |
| Current ratio (mrq) | 3.10 |
| Book value per share (mrq) | 0.28 |
Cash flow statement
| Operating cash flow (ttm) | -48.48M |
| Levered free cash flow (ttm) | -24.63M |
© 2024 Yahoo. All rights reserved.